Milad Alucozai
venture capitalist, neuroscientist, and entrepreneur in San Francisco, California
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has nearly 20 years of experience translating exceptional science and technology into scalable commercial ventures. As a founder and operator, he has invested in over 100 startups across North America and Europe. He has frequently been the first investor in many high-growth companies, such as Seqera Labs. Dr. Alucozai began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.